| Literature DB >> 9130582 |
Y Iikura1, T Matsumoto, K Fujita, T Otsuka, Y Sakamoto, S K Yun, H Saito, T Obata, A Akasawa, M C Capulong, N Sakaguchi, Y Oya, K Tahara, H Tachimoto, H Kawahara, N Koya.
Abstract
We studied the 1-type isoproterenol inhalation therapy for patients with severe asthmatic attacks who were admitted at the Department of Allergy of National Children's Hospital from 1981 to 1991. One hour after l-type isoproterenol inhalation therapy, statistically significant effects were noted with regard to the asthmatic status. Moreover, no side effect was found amoung the subjects. From these data, 1-type isoproterenol inhalation therapy is thought to be effective for severe asthmatic attacks.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9130582 DOI： 10.1159/000237606
Source DB: PubMed Journal: Int Arch Allergy Immunol ISSN： 1018-2438 Impact factor: 2.749